Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Rebound insomnia: a new clinical syndrome.

Rebound insomnia: a new clinical syndrome. Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods. The intense worsening of sleep is attributed to the short duration of the action of these drugs. A hypothesis involving benzodiazepine receptors in the brain is proposed in which there is a delay or lag in replacement of endogenous benzodiazepine-like molecules after the abrupt withdrawal of exogenous drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Science (New York, N.Y.) Pubmed

Rebound insomnia: a new clinical syndrome.

Science (New York, N.Y.) , Volume 201 (4360): -997 – Oct 25, 1978

Rebound insomnia: a new clinical syndrome.


Abstract

Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods. The intense worsening of sleep is attributed to the short duration of the action of these drugs. A hypothesis involving benzodiazepine receptors in the brain is proposed in which there is a delay or lag in replacement of endogenous benzodiazepine-like molecules after the abrupt withdrawal of exogenous drugs.

Loading next page...
 
/lp/pubmed/rebound-insomnia-a-new-clinical-syndrome-E08nPwHr0A

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0036-8075
DOI
10.1126/science.684426
pmid
684426

Abstract

Rebound insomnia followed the withdrawal of three benzodiazepine hypnotic drugs, each of which had been administered in a single nightly dose for only short-term periods. The intense worsening of sleep is attributed to the short duration of the action of these drugs. A hypothesis involving benzodiazepine receptors in the brain is proposed in which there is a delay or lag in replacement of endogenous benzodiazepine-like molecules after the abrupt withdrawal of exogenous drugs.

Journal

Science (New York, N.Y.)Pubmed

Published: Oct 25, 1978

There are no references for this article.